Kevin Weaver

Kevin Weaver is an experienced Senior Process Engineer specializing in lipid nanoparticle manufacturing, currently working at Intellia Therapeutics, Inc. since October 2024. Previously, Kevin held various engineering roles at Verve Therapeutics from August 2022 to November 2024, where responsibilities included executing studies for manufacturing optimization, managing lab operations, and collaborating with cross-functional teams for process improvements. Prior experience at Alnylam Pharmaceuticals spanned from June 2017 to August 2022, involving the development of data monitoring platforms, authoring SOPs, and supporting manufacturing operations. Kevin’s career began with an internship at Imperial College, where skills in process analysis and plant operations were developed. Kevin holds a Bachelor’s Degree in Chemical Engineering from the University of Notre Dame.